Pharmaceutical company, Moderna Inc., says its Covid-19 vaccine is 94.5% effective in treating coronavirus, after preliminary analysis of a large late-stage clinical trial.
Moderna disclosed this today in a report by Bloomberg, as it joins other companies including Pfizer in reporting above 90% effectiveness of a vaccine for the global pandemic.
What you should know
Nairametrics reported last week that Pfizer Inc disclosed that its experimental vaccine, which it jointly developed with BioNTech was more than 90% effective in preventing COVID-19, based on initial data from a large study, in the ongoing phase 3 trials.
The European Union finalized a deal to buy up to 300 million doses of the ground-breaking coronavirus vaccine developed by BioNTech and Pfizer.